Acadia Healthcare (NASDAQ:ACHC) Given New $90.00 Price Target at Bank of America

Acadia Healthcare (NASDAQ:ACHC) had its target price cut by Bank of America from $105.00 to $90.00 in a research report released on Thursday, Benzinga reports. They currently have a buy rating on the stock.

A number of other research analysts also recently weighed in on ACHC. TheStreet raised Acadia Healthcare from a c rating to a b- rating in a research note on Monday, March 4th. Barclays cut their price target on shares of Acadia Healthcare from $100.00 to $91.00 and set an overweight rating on the stock in a research report on Thursday. UBS Group boosted their price objective on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a buy rating in a report on Wednesday, February 28th. Royal Bank of Canada reiterated an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, TD Cowen boosted their price target on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an outperform rating in a report on Friday, March 1st. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of Moderate Buy and a consensus target price of $89.50.

Acadia Healthcare Trading Down 0.9 %

ACHC traded down $0.61 during mid-day trading on Thursday, reaching $66.12. The stock had a trading volume of 1,181,258 shares, compared to its average volume of 604,466. The stock has a market capitalization of $6.11 billion, a P/E ratio of -472.29, a P/E/G ratio of 2.15 and a beta of 1.31. Acadia Healthcare has a 52 week low of $64.74 and a 52 week high of $87.77. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The firm’s fifty day simple moving average is $77.13 and its two-hundred day simple moving average is $77.61.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.56% and a negative net margin of 0.38%. The firm had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. During the same period last year, the company earned $0.75 earnings per share. The company’s revenue was up 9.1% on a year-over-year basis. On average, equities analysts predict that Acadia Healthcare will post 3.57 EPS for the current year.

Insiders Place Their Bets

In other news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth about $26,000. Headlands Technologies LLC acquired a new stake in Acadia Healthcare during the third quarter worth approximately $25,000. Mather Group LLC. bought a new stake in shares of Acadia Healthcare during the first quarter worth approximately $48,000. Fifth Third Bancorp increased its stake in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new stake in Acadia Healthcare during the 3rd quarter worth approximately $96,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.